Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free VERA Stock Alerts

Vera Therapeutics (VERA) Short Interest Ratio & Short Volume

Vera Therapeutics logo
$27.72 -2.16 (-7.23%)
Closing price 10/12/2026 04:00 PM Eastern
Extended Trading
$27.70 -0.02 (-0.09%)
As of 08:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Vera Therapeutics Short Interest Overview

As of September 30, 2026, Vera Therapeutics (VERA) had a short interest of 17.24 million shares sold short, representing 28.45% of the public float. This marks a 1.21% increase in short interest since the prior report. The short interest ratio (days to cover) is 7.8, meaning it would take 7.8 days of the average trading volume of 2.54 million shares to cover all short positions.

Current Short Interest
17,240,397 shares
Previous Short Interest
17,035,040 shares
Change Vs. Previous Month
1.21%
Dollar Volume Sold Short
$556.69 million
Short Interest Ratio
7.8 Days to Cover
Last Record Date
September 30, 2026
Outstanding Shares
72,060,000 shares
Short Percent of Float
28.45%
Today's Trading Volume
1,405,319 shares
Average Trading Volume
2,541,947 shares
Today's Volume Vs. Average
55%
Short Selling Vera Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Vera Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

VERA Short Interest Over Time

VERA Days to Cover Over Time

VERA Percentage of Float Shorted Over Time

Vera Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202617,240,397 shares $556.69 million +1.2%28.4%7.79 $32.29
9/15/202617,035,040 shares $573.57 million -14.3%28.1%6.18 $33.67
8/31/202619,873,297 shares $677.28 million +18.2%32.8%10.81 $34.08
8/14/202616,814,429 shares $531.84 million +10.0%27.7%6.95 $31.63
7/31/202615,281,960 shares $490.55 million +1.3%25.3%9.42 $32.10
7/15/202615,081,995 shares $640.98 million +11.6%25.0%4.99 $42.50
6/30/202613,520,658 shares $580.17 million +14.2%22.4%5.87 $42.91
6/15/202611,839,194 shares $405.37 million +9.3%19.6%10.4 $34.24
5/29/202610,833,205 shares $384.80 million +7.5%17.9%11.18 $35.52
5/15/202610,077,450 shares $376.09 million +7.4%16.7%9.98 $37.32
4/30/20269,386,187 shares $334.24 million -4.9%15.6%9.5 $35.61
4/15/20269,872,666 shares $428.97 million +1.1%16.4%6.93 $43.45
3/31/20269,764,156 shares $392.81 million +18.3%16.2%7.85 $40.23
3/13/20268,250,811 shares $329.70 million +8.0%13.8%6.19 $39.96
2/27/20267,638,754 shares $311.58 million -4.9%13.0%8.15 $40.79
2/13/20268,033,354 shares $339.17 million -0.8%13.3%8.28 $42.22
1/30/20268,094,375 shares $350.16 million +0.6%15.1%7.83 $43.26
1/15/20268,045,451 shares $372.34 million -4.9%15.0%7.03 $46.28
12/31/20258,459,021 shares $428.36 million -7.5%15.8%7.13 $50.64
12/15/20259,145,275 shares $450.04 million -15.5%17.1%4.05 $49.21
11/28/202510,818,660 shares $366.10 million +8.6%20.2%7.79 $33.84
11/14/20259,962,227 shares $282.43 million +7.6%18.6%4.93 $28.35
10/31/20259,259,969 shares $263.54 million -5.1%17.3%8.26 $28.46
10/15/20259,760,000 shares $302.56 million -1.8%20.1%6.4 $31.00
9/30/20259,940,000 shares $288.86 million +6.2%20.5%6.7 $29.06
9/15/20259,360,000 shares $226.89 million +10.4%19.3%6.3 $24.24
8/31/20258,480,000 shares $183.51 million +9.1%17.5%5.6 $21.64
8/15/20257,770,000 shares $167.37 million +2.6%16.0%4.2 $21.54
7/31/20257,570,000 shares $157.38 million -8.1%15.9%4.5 $20.79
7/15/20258,240,000 shares $191.17 million +5,059.7%18.1%4.8 $23.20
6/30/2025159,700 shares $3.76 million -98.3%0.2%0.7 $23.56
6/15/20259,560,000 shares $217.39 million +6.8%20.8%5.5 $22.74
5/31/20258,950,000 shares $170.23 million +26.6%18.6%5.7 $19.02
5/15/20257,070,000 shares $150.80 million +18.6%14.7%7.1 $21.33
4/30/20255,960,000 shares $139.29 million -2.0%12.2%5.4 $23.37
4/15/20256,080,000 shares $131.27 million -7.0%12.4%6.4 $21.59
3/31/20256,540,000 shares $157.09 million -9.8%13.4%7 $24.02
3/15/20257,250,000 shares $202.93 million -7.1%14.8%8.6 $27.99
2/28/20257,800,000 shares $233.45 million -6.7%15.9%9.8 $29.93
2/15/20258,360,000 shares $229.57 million +3.2%17.2%11 $27.46
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
1/31/20258,100,000 shares $301.97 million +11.1%16.6%12.2 $37.28
1/15/20257,290,000 shares $246.99 million +2.0%14.9%9.2 $33.88
12/31/20247,150,000 shares $302.37 million +5.2%14.6%9.8 $42.29
12/15/20246,800,000 shares $299.54 million +4.3%13.9%9.3 $44.05
11/30/20246,520,000 shares $324.37 million -0.5%13.3%8.6 $49.75
11/15/20246,550,000 shares $303.00 million +2.5%14.0%8.7 $46.26
10/31/20246,390,000 shares $258.03 million +3.2%13.3%9 $40.38
10/15/20246,190,000 shares $248.90 million +0.3%14.9%11.7 $40.21
9/30/20246,170,000 shares $272.71 million -4.5%14.9%11.3 $44.20
9/15/20246,460,000 shares $242.31 million +6.8%15.6%11.6 $37.51
8/31/20246,050,000 shares $228.81 million -0.5%14.6%11.3 $37.82
8/15/20246,080,000 shares $226.42 million -0.2%14.7%9.9 $37.24
7/31/20246,090,000 shares $222.83 million +1.7%14.7%9.4 $36.59
7/15/20245,990,000 shares $220.13 million -2.1%14.4%8.2 $36.75
6/30/20246,120,000 shares $221.42 million -0.1%14.7%6.9 $36.18
6/15/20246,123,800 shares $220.58 million +0.9%14.7%6.7 $36.02
5/31/20246,070,000 shares $230.60 million -6.0%14.5%6.6 $37.99
5/15/20246,460,000 shares $275.78 million -5.0%15.5%6.7 $42.69
4/30/20246,800,000 shares $268.67 million +7.8%16.6%6.5 $39.51
4/15/20246,310,000 shares $293.60 million -0.3%16.1%4.5 $46.53
3/31/20246,330,000 shares $272.95 million +1.4%16.1%4.9 $43.12
3/15/20246,240,000 shares $269.88 million +0.7%16.2%5.1 $43.25
2/29/20246,200,000 shares $291.90 million -8.4%16.5%5.3 $47.08
2/15/20246,770,000 shares $308.10 million +2.4%19.6%6.3 $45.51
1/31/20246,610,000 shares $240.74 million +9.3%19.1%6.6 $36.42
1/15/20246,050,000 shares $114.65 million -3.7%21.5%10.3 $18.95
12/31/20236,280,000 shares $96.59 million +11.2%22.2%11.3 $15.38
12/15/20235,650,000 shares $90.40 million +5.6%20.0%10.7 $16.00
11/30/20235,350,000 shares $72.49 million +6.6%19.0%9.3 $13.55
11/15/20235,020,000 shares $67.07 million +1.2%17.8%8.5 $13.36
10/31/20234,960,000 shares $51.68 million -9.3%17.8%8.8 $10.42
10/15/20235,470,000 shares $58.20 million +11.9%19.9%10.7 $10.64
9/30/20234,890,000 shares $67.04 million +32.9%17.8%10.3 $13.71
9/15/20233,680,000 shares $62.89 million -2.9%13.4%7.3 $17.09
8/31/20233,790,000 shares $67.05 million +15.9%13.8%5.4 $17.69
8/15/20233,270,000 shares $57.85 million +6.2%11.9%4.7 $17.69
7/31/20233,080,000 shares $57.81 million -8.3%11.1%4.5 $18.77
7/15/20233,360,000 shares $56.92 million -2.6%12.3%5 $16.94
6/30/20233,450,000 shares $55.37 million -3.1%12.7%5.1 $16.05
6/15/20233,560,000 shares $45.28 million +24.5%13.4%5.6 $12.72
5/31/20232,860,000 shares $23.88 million -5.0%10.8%7.3 $8.35
5/15/20233,010,000 shares $23.99 million -9.1%11.3%7.5 $7.97
4/30/20233,310,000 shares $22.01 million +30.3%14.2%7.1 $6.65
4/15/20232,540,000 shares $15.93 million -28.9%9.7%4.6 $6.27
3/31/20233,570,000 shares $27.70 million +32.7%14.2%5.4 $7.76
3/15/20232,690,000 shares $19.18 million +15.5%10.7%3.2 $7.13
2/28/20232,330,000 shares $17.31 million +3.6%9.1%3 $7.43
2/15/20232,250,000 shares $17.71 million +47.1%8.8%3.1 $7.87
1/31/20231,530,000 shares $12.97 million +23.4%7.6%2.3 $8.48
1/15/20231,240,000 shares $8.36 million -12.1%9.3%2.4 $6.74
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
12/30/20221,410,000 shares $27.28 million -7.2%10.6%3.4 $19.35
12/15/20221,520,000 shares $29.14 million -22.1%11.4%11.7 $19.17
11/30/20221,950,000 shares $32.57 million -4.9%14.7%16 $16.70
11/15/20222,050,000 shares $34.54 million +15.8%15.5%18.9 $16.85
10/31/20221,770,000 shares $32.99 million +10.6%14.7%18.1 $18.64
10/15/20221,600,000 shares $30.69 million -1.2%13.3%18.6 $19.18
9/30/20221,620,000 shares $34.52 million +14.9%13.4%18.8 $21.31
9/15/20221,410,000 shares $30.13 million -10.2%11.7%16.2 $21.37
8/31/20221,570,000 shares $34.12 million +4.0%13.2%18 $21.73
8/15/20221,510,000 shares $32.69 million +14.4%12.6%18.9 $21.65
7/31/20221,320,000 shares $22.77 million +16.8%11.1%15 $17.25
7/15/20221,130,000 shares $18.14 million +20.1%9.5%12 $16.05
6/30/2022941,300 shares $12.81 million +28.2%7.9%10.2 $13.61
6/15/2022734,500 shares $10.28 million +83.6%6.2%8.2 $13.99
5/31/2022400,000 shares $5.82 million -12.5%3.3%4.1 $14.54
5/15/2022456,900 shares $6.99 million +8.1%3.8%4.7 $15.29
4/30/2022422,600 shares $8.45 million +41.2%3.4%3.6 $20.00
4/15/2022299,200 shares $6.92 million -46.3%2.4%2.7 $23.12
3/31/2022557,000 shares $13.08 million +40.1%4.5%5.3 $23.49
3/15/2022397,700 shares $9.55 million +39.1%3.1%3.6 $24.01
2/28/2022286,000 shares $6.64 million -16.7%2.2%2.8 $23.21
2/15/2022343,400 shares $6.81 million -4.3%3.7%3.5 $19.83
1/31/2022358,800 shares $7.15 million +27.9%4.9%5.2 $19.93
1/15/2022280,600 shares $5.61 million +15.6%3.8%4.6 $19.99
12/31/2021242,700 shares $6.48 million +185.2%3.3%4.2 $26.72
12/15/202185,100 shares $1.92 million +7.2%1.2%1.4 $22.51
11/30/202179,400 shares $2.84 million -36.6%1.1%1 $35.80
11/15/2021125,200 shares $2.93 million -32.4%1.7%1.6 $23.40
10/29/2021185,100 shares $3.58 million +43.8%2.5%2.6 $19.35
10/15/2021128,700 shares $1.93 million +15.8%1.7%1.8 $15.01

VERA Short Interest - Frequently Asked Questions

Short interest is the volume of Vera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 17,240,397 shares of VERA short. 28.45% of Vera Therapeutics' shares are currently sold short. Learn More on Vera Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VERA shares currently have a short interest ratio of 7.8. Learn More on Vera Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 28.45% of Vera Therapeutics' floating shares are currently sold short.

Vera Therapeutics saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 17,240,397 shares, an increase of 1.2% from the previous total of 17,035,040 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

28.45% of Vera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Vera Therapeutics: Vaxcyte, Inc. (12.02%), Apogee Therapeutics Inc. (8.93%), TG Therapeutics, Inc. (21.96%), Spyre Therapeutics, Inc. (17.33%), Abivax SA Sponsored ADR (8.90%), Praxis Precision Medicines, Inc. (15.46%), Cytokinetics, Incorporated (15.95%), Ionis Pharmaceuticals, Inc. (13.79%), Alkermes plc (11.13%), Immunovant, Inc. (8.60%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks.

Short selling VERA is an investing strategy that aims to generate trading profit from Vera Therapeutics as its price is falling. VERA shares are trading down $2.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Vera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VERA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VERA, twice per month. The most recent reporting period available is September, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like VERA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:VERA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel